DR-70 tumor marker: Will begin a Canadian clinical trial this month

AMDL Inc. (AMDD) Product: DR-70 tumor marker Indication: Identification of lung cancer Status: Will begin a Canadian clinical trial this month Note: AMDD also has started testing of nearly 600 blood s...